| Structure | Chemical Name | CAS | MF |
|
Ethyl [2-(cyanoamino)-4-hydroxypyrimidin-5-yl]acetate
|
1338494-91-9
|
C9H10N4O3
|
|
4-[(4-Bromophenyl)methyl]oxane-4-carboxylic acid
|
1338494-92-0
|
C13H15BrO3
|
|
tert-Butyl [1-(2-chloro-5-fluoropyrimidin-4-yl)piperidin-4-yl]carbamate
|
1338494-93-1
|
C14H20ClFN4O2
|
|
2-(2-Methoxyethoxy)-4-methyl-1,3-thiazole-5-carboxylic acid
|
1338494-94-2
|
C8H11NO4S
|
|
2,2,2-Trichloro-1-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)ethanol
|
1338494-96-4
|
C9H13Cl3N2O
|
|
3-Bromo-5-methoxy-1-(tetrahydro-2H-pyran-2-yl)-1H-1,2,4-triazole
|
1338495-01-4
|
C8H12BrN3O2
|
|
tert-Butyl 4-[(1-ethyl-1H-pyrazol-3-yl)-carbonyl]piperazine-1-carboxylate
|
1338495-02-5
|
C15H24N4O3
|
|
2,2,2-Trichloro-1-(1-ethyl-5-methyl-1H-pyrazol-4-yl)ethanol
|
1338495-04-7
|
C8H11Cl3N2O
|
|
[1-Allyl-1-(tetrahydro-2H-pyran-4-yl)but-3-en-1-yl]amine
|
1338495-06-9
|
C12H21NO
|
|
N-(4-Fluoro-2-isopropoxyphenyl)-pyrrolidine-1-carbothioamide
|
1338495-07-0
|
C14H19FN2OS
|
|
N,6-Dimethyl-3-(trifluoromethyl)-6H-1,2,4-oxadiazin-5-amine
|
1338495-08-1
|
C6H8F3N3O
|
|
N-Methyl-3-(trifluoromethyl)-6H-1,2,4-oxadiazin-5-amine
|
1338495-10-5
|
C5H6F3N3O
|
|
2-[(4-Amino-3,5-dimethyl-1H-pyrazol-1-yl)methyl]benzoic acid
|
1338495-11-6
|
C13H15N3O2
|
|
(7-Hydroxy[1,2,4]triazolo-[1,5-a]pyrimidin-6-yl)acetic acid
|
1338495-14-9
|
C7H6N4O3
|
|
2,2,2-Trichloro-1-(1-ethyl-1H-pyrazol-4-yl)ethanol
|
1338495-16-1
|
C7H9Cl3N2O
|
|
2,2,2-Trichloro-1-(1-methyl-1H-pyrazol-4-yl)ethanol
|
1338495-17-2
|
C6H7Cl3N2O
|
|
4-[(2-Bromophenyl)methyl]oxane-4-carboxylic acid
|
1338495-18-3
|
C13H15BrO3
|
|
tert-Butyl 4-(2-chloro-5-fluoropyrimidin-4-yl)piperazine-1-carboxylate
|
1338495-22-9
|
C13H18ClFN4O2
|
|
2-Chloro-N-cyclopentyl-5-fluoropyrimidin-4-amine
|
1338495-23-0
|
C9H11ClFN3
|
|
[3-(Trifluoromethyl)-1,2,4-oxadiazol-5-yl]methanol
|
1338495-26-3
|
C4H3F3N2O2
|
|
2-Chloro-3-(3,5-dimethyl-1H-pyrazol-1-yl)propanenitrile
|
1338495-27-4
|
C8H10ClN3
|
|
2-(Chloromethyl)[1,2,4]triazolo[1,5-a]pyrimidine
|
1338495-29-6
|
C6H5ClN4
|
|
2-Hydroxy-6-methyl-1,2,3,4-tetrahydroquinoline-4-carboxylic acid
|
1338495-31-0
|
C11H13NO3
|
|
2,2,2-Trichloro-1-(1,3-dimethyl-1H-pyrazol-4-yl)ethanol
|
1338495-32-1
|
C7H9Cl3N2O
|
|
Cefepime Impurity 3
|
1338535-10-6
|
C19H25N6O6S2+
|
|
OTS514
|
1338540-55-8
|
C20H18N2O2S
|
|
OTS514
|
1338540-63-8
|
C21H20N2O2S
|
|
OTS964
|
1338542-14-5
|
C23H24N2O2S
|
|
9-bromo-8-methoxy-6-methylthieno[2,3-c]quinolin-4(5H)-one
|
1338543-46-6
|
C13H10BrNO2S
|
|
9-Bromo-8-methoxythieno[2,3-c]quinolin-4(5H)-one
|
1338543-57-9
|
C12H8BrNO2S
|
|
tert-butyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate
|
1338544-06-1
|
C22H34BNO4
|
|
(R)-9-(4-(1-(dimethylamino)propan-2-yl)phenyl)-8-hydroxythieno[2,3-c]quinolin-4(5H)-one hydrochloride
|
1338545-01-9
|
C22H23ClN2O2S
|
|
OTS964 hydrochloride
|
1338545-07-5
|
C23H24N2O2S
|
|
tert-Butyl 2,3-dihydro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-inden-2-ylcarbamate
|
1338547-17-3
|
C20H30BNO4
|
|
Pregna-1,4-diene-3,20-dione, 11,21,21-trihydroxy-6-methyl-, (6α,11β)-
|
1338549-01-1
|
C22H30O5
|
|
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al
|
1338549-02-2
|
C22H28O4
|
|
ethyl 1-oxo-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-7-carboxylate
|
1338563-13-5
|
C10H12N2O3
|
|
Methyl 5-(chloromethyl)-2-fluorobenzoate
|
1338563-94-2
|
C9H8ClFO2
|
|
Propargyl-PEG1-CH2COOtBu
|
1338564-52-5
|
C11H18O4
|
|
Propargyl-PEG2-CH2COOtBu
|
1338564-53-6
|
C13H22O5
|
|
N-[[1,1'-Biphenyl]-3-ylmethyl)-N-methylcarbamic acid 4'-(aminocarbonyl)[1,1'-biphenyl]-4-yl ester
|
1338574-83-6
|
C28H24N2O3
|
|
WWL 154
|
1338574-93-8
|
C18H19N3O5
|
|
WWL229
|
1338575-28-2
|
C16H22N2O5
|
|
WWL123
|
1338575-41-9
|
C28H24N2O3
|
|
Somapacitan
|
1338578-34-9
|
|
|
2,7,2',7'-TTBrSFX
|
1338596-81-8
|
C25H12Br4O
|
|
2-(3-broMo-4-Methylphenylthio)ethanol
|
1338603-02-3
|
C9H11BrOS
|
|
Tri(2-Fmoc-aminoethyl) amine
|
1338643-94-9
|
C51H48N4O6
|
|
(6-Methoxy-benzothiazol-2-yl)-carbaMic acid tert-butyl ester
|
1338645-97-8
|
C13H16N2O3S
|
|
2-(3-Fluorophenyl)pyrazolo[1,5-a]pyrazin-4(5H)-one
|
1338651-03-8
|
C12H8FN3O
|
|
2-Amino-4-[(Boc-amino)methyl]pyrimidine
|
1338651-80-1
|
C10H16N4O2
|
|
(5-Iodo-3-nitro-pyridin-2-yl)-methyl-amine
|
1338652-31-5
|
C6H6IN3O2
|
|
8-Fluoro-1,3,4,5-tetrahydrobenzo-[b]-1,6-naphthyridin-10(2H)-one
|
1338652-61-1
|
C12H11FN2O
|
|
6-Fluoro-4-methoxy-8-methylquinoline-2-carboxylicacid
|
1338661-72-5
|
C12H10FNO3
|
|
[7-(3-Methyl-1,2,4-oxadiazol-5-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]aceticacid
|
1338661-82-7
|
C11H9N5O3
|
|
2-(2-Methylphenyl)-4H,5H-pyrazolo[1,5-a]pyrazin-4-one
|
1338664-59-7
|
C13H11N3O
|
|
2-(4-Isopropylphenyl)pyrazolo[1,5-a]pyrazin-4(5H)-one
|
1338666-95-7
|
C15H15N3O
|
|
1-[(1-Phenyl-1H-1,2,3-triazol-5-yl)methyl]piperazinedihydrochloride
|
1338667-74-5
|
C13H17N5
|
|
3-(2,5-Dimethoxyphenyl)-6-piperazin-1-ylpyridazine
|
1338671-24-1
|
C16H20N4O2
|
|
1-Boc-4-hydrazinocarbonylmethyl piperazine
|
1338673-52-1
|
C11H22N4O3
|
|
Methyl 4-((3-methyl-1,2,4-oxadiazol-5-yl)methoxy)benzoate
|
1338673-74-7
|
C12H12N2O4
|
|
1-[6-(3-Fluorophenyl)pyridazin-3-yl]piperidin-4-amine
|
1338674-66-0
|
C15H17FN4
|
|
4-(3-tert-Butyl-1,2,4-oxadiazol-5-yl)-2-chloropyridine
|
1338675-20-9
|
C11H12ClN3O
|
|
3-(2-Methoxyphenyl)-6-piperazin-1-ylpyridazine
|
1338675-85-6
|
C15H18N4O
|
|
Alogliptin Related CoMpound 5
|
1338677-76-1
|
C10H16N4O2
|
|
[7-(3-Ethyl-1,2,4-oxadiazol-5-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]aceticacid
|
1338682-10-2
|
C12H11N5O3
|
|
3-p-Tolyl-isothiazole-5-carboxylic acid
|
1338682-63-5
|
C11H9NO2S
|
|
6-(3-Methyl-1,2,4-oxadiazol-5-yl)-4,5-dihydropyridazin-3(2H)-one
|
1338682-74-8
|
C7H8N4O2
|
|
8-Fluoro-4-methoxyquinoline-2-carboxylic acid
|
1338683-24-1
|
C11H8FNO3
|
|
4-Chloro-2-(3-fluorophenyl)pyrazolo[1,5-a]pyrazine
|
1338690-83-7
|
C12H7ClFN3
|
|
2-(4-Fluoro)-phenylpyrazolo[1,5-a]pyrazin-4(5H)-one
|
1338692-17-3
|
C12H8FN3O
|
|
1-{[1-(2-Fluorophenyl)-1H-1,2,3-triazol-5-yl]methyl}piperazinedihydrochloride
|
1338692-39-9
|
C13H16FN5
|
|
Eg5-I
|
1338701-15-7
|
C23H25NO2S
|
|
5,6,7,8-Tetrahydro-1,7-naphthyridine hydrochloride
|
1338707-67-7
|
C8H11ClN2
|
|
1,2,3,4-Tetrahydro-1,5-naphthyridine
|
1338707-93-9
|
C8H11ClN2
|
|
2-(4-cyclopropyl-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1338718-13-0
|
C15H20BFO2
|
|
1H-Pyrazole,5-chloro-1-ethyl-4-nitro-
|
1338718-34-5
|
C5H6ClN3O2
|
|
5-chloro-1-cyclopropyl-4-nitro-1H-Pyrazole
|
1338718-38-9
|
C6H6ClN3O2
|
|
1-(3-Oxetanyl)-1H-pyrazol-4-aMine
|
1338719-26-8
|
C6H9N3O
|
|
Phenol, 4-(cyclohexylideneaMino)-3-fluoro-
|
1338722-54-5
|
C12H14FNO
|
|
OC1801, 2,2'-(2,5-Dimethoxy-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
|
1338777-82-4
|
C20H32B2O6
|
|
AU1235
|
1338780-86-1
|
C17H19F3N2O
|
|
3,7,11,15,19-Pentamethyl-2,6,10,14,18-eicosapentaenoic Acid Ethyl Ester
|
1338789-42-6
|
C27H44O2
|
|
CarbaMic acid, N-[3-[3-(aMinosulfonyl)phenyl]-1H-indazol-5-yl]-, 1,1-diMethylethyl ester
|
1338792-02-1
|
C18H20N4O4S
|
|
4-broMo-2,3-diMethylaniline hydrobroMide
|
1338796-79-4
|
C8H11Br2N
|
|
CFI-400945
|
1338800-06-8
|
C33H34N4O3
|
|
Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid)
|
1338800-81-9
|
C17H21N3O4
|
|
Anastrozole IMpurity (3-(1-Cyano-1-Methylethyl)-alfa,alfa-diMethyl-5-(1H-,1,2,4-triazole-1-ylMethyl)-benzeneacetic acid)
|
1338800-82-0
|
C17H20N4O2
|
|
ethyl 10-(diethoxyphosphoryl)decanoate
|
1338801-94-7
|
C16H33O5P
|
|
N-phenyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-[1,1'-biphenyl]-4-amine
|
1338803-75-0
|
C30H30BNO2
|
|
CFI-400945
|
1338806-73-7
|
C33H34N4O3
|
|
trans-tert-Butyl 3-hydroxy-2,2,4,4-(tetraMethyl)cyclobutylcarbaMate
|
1338812-41-1
|
C13H25NO3
|
|
(1r,3r)-3-amino-2,2,4,4-tetramethylcyclobutanol phosphorous acid
|
1338812-52-4
|
C8H20NO5P
|
|
Nebivolol Related Compound 1 HCl (Mixture of (RR,SR) and (SS,RS) Isomer)
|
1338823-20-3
|
C22H26ClF2NO4
|
|
Lysine(crotonyl)-OH
|
1338823-35-0
|
C10H18N2O3
|
|
ML224
|
1338824-21-7
|
C31H31N3O5
|
|
4''-[[[2-Methyl-4-(1-methyl-1H-benzimidazol-2-yl)-6-nitrophenyl](1-oxobutyl)amino]methyl]-[1,1''-biphenyl]-2-carboxylic Acid Methyl Ester
|
1338830-33-3
|
C34H32N4O5
|
|
TelMisartan EP IMpurity B Methyl Ester
|
1338830-37-7
|
C34H32N4O2
|
|
Isoquinoline, 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
1338914-81-0
|
C15H18BNO2
|
|
4,4,5,5-tetramethyl-2-[3-(2-methylpropoxy)phenyl]-1,3,2-dioxaborolane
|
1338916-31-6
|
C16H25BO3
|